MedPath

Digital Measures of Neuropsychological Tests

Conditions
80 healthy participants and 80 Early Stage Alzheimer Disease (AD) patients.
Registration Number
NL-OMON27881
Lead Sponsor
Philips Research Eindhoven
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
160
Inclusion Criteria

In order to be eligible to participate in this study, an AD patient must meet all of the following criteria:

1.Aged 60 and older

Exclusion Criteria

A potential AD patient who meets any of the following criteria will be excluded from participation in this study:

1.Unable or incompetent to give written informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The aim of the study is to collect digital data for the (digital) tests that are currently hosted on the Cognitive Dx platform and to use this data to develop and refine the existing algo-rithms that automatically score the test. The algorithms will be developed and refined based on the manual scores from the neuropsychologist.
Secondary Outcome Measures
NameTimeMethod
1.To compare specific digital measures, or combination of digital measures, that are gen-erated by the algorithms and to discover if these are different for Alzheimer patients as compared to healthy individuals.<br /><br>2.Evaluate the usability of the digitized test platform in the healthy and AD population
© Copyright 2025. All Rights Reserved by MedPath